Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture

Approximately 10,000 cases of tick-borne encephalitis (TBE), a serious disease of the central nervous system caused by tick-borne encephalitis virus (TBEV), are registered worldwide every year. Vaccination against TBE remains the most essential measure of preventing the disease. Unlike available TBE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Vorovitch, Mikhail F., Grishina, Karina G., Volok, Viktor P., Chernokhaeva, Liubov L., Grishin, Konstantin V., Karganova, Galina G., Ishmukhametov, Aidar A.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7553679/
https://ncbi.nlm.nih.gov/pubmed/32429733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1757990
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados